Cargando…
Fluorescence guided surgery and tracer-dose, fact or fiction?
INTRODUCTION: Fluorescence guidance is an upcoming methodology to improve surgical accuracy. Challenging herein is the identification of the minimum dose at which the tracer can be detected with a clinical-grade fluorescence camera. Using a hybrid tracer such as indocyanine green (ICG)-(99m)Tc-nanoc...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4969335/ https://www.ncbi.nlm.nih.gov/pubmed/27020580 http://dx.doi.org/10.1007/s00259-016-3372-y |
_version_ | 1782445766474727424 |
---|---|
author | KleinJan, Gijs H. Bunschoten, Anton van den Berg, Nynke S. Olmos, Renato A. Valdès Klop, W. Martin C. Horenblas, Simon van der Poel, Henk G. Wester, Hans-Jürgen van Leeuwen, Fijs W. B. |
author_facet | KleinJan, Gijs H. Bunschoten, Anton van den Berg, Nynke S. Olmos, Renato A. Valdès Klop, W. Martin C. Horenblas, Simon van der Poel, Henk G. Wester, Hans-Jürgen van Leeuwen, Fijs W. B. |
author_sort | KleinJan, Gijs H. |
collection | PubMed |
description | INTRODUCTION: Fluorescence guidance is an upcoming methodology to improve surgical accuracy. Challenging herein is the identification of the minimum dose at which the tracer can be detected with a clinical-grade fluorescence camera. Using a hybrid tracer such as indocyanine green (ICG)-(99m)Tc-nanocolloid, it has become possible to determine the accumulation of tracer and correlate this to intraoperative fluorescence-based identification rates. In the current study, we determined the lower detection limit of tracer at which intraoperative fluorescence guidance was still feasible. METHODS: Size exclusion chromatography (SEC) provided a laboratory set-up to analyze the chemical content and to simulate the migratory behavior of ICG-nanocolloid in tissue. Tracer accumulation and intraoperative fluorescence detection findings were derived from a retrospective analysis of 20 head-and-neck melanoma patients, 40 penile and 20 prostate cancer patients scheduled for sentinel node (SN) biopsy using ICG-(99m)Tc-nanocolloid. In these patients, following tracer injection, single photon emission computed tomography fused with computed tomography (SPECT/CT) was used to identify the SN(s). The percentage injected dose (% ID), the amount of ICG (in nmol), and the concentration of ICG in the SNs (in μM) was assessed for SNs detected on SPECT/CT and correlated with the intraoperative fluorescence imaging findings. RESULTS: SEC determined that in the hybrid tracer formulation, 41 % (standard deviation: 12 %) of ICG was present in nanocolloid-bound form. In the SNs detected using fluorescence guidance a median of 0.88 % ID was present, compared to a median of 0.25 % ID in the non-fluorescent SNs (p-value < 0.001). The % ID values could be correlated to the amount ICG in a SN (range: 0.003–10.8 nmol) and the concentration of ICG in a SN (range: 0.006–64.6 μM). DISCUSSION: The ability to provide intraoperative fluorescence guidance is dependent on the amount and concentration of the fluorescent dye accumulated in the lesion(s) of interest. Our findings indicate that intraoperative fluorescence detection with ICG is possible above a μM concentration. |
format | Online Article Text |
id | pubmed-4969335 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-49693352016-08-17 Fluorescence guided surgery and tracer-dose, fact or fiction? KleinJan, Gijs H. Bunschoten, Anton van den Berg, Nynke S. Olmos, Renato A. Valdès Klop, W. Martin C. Horenblas, Simon van der Poel, Henk G. Wester, Hans-Jürgen van Leeuwen, Fijs W. B. Eur J Nucl Med Mol Imaging Original Article INTRODUCTION: Fluorescence guidance is an upcoming methodology to improve surgical accuracy. Challenging herein is the identification of the minimum dose at which the tracer can be detected with a clinical-grade fluorescence camera. Using a hybrid tracer such as indocyanine green (ICG)-(99m)Tc-nanocolloid, it has become possible to determine the accumulation of tracer and correlate this to intraoperative fluorescence-based identification rates. In the current study, we determined the lower detection limit of tracer at which intraoperative fluorescence guidance was still feasible. METHODS: Size exclusion chromatography (SEC) provided a laboratory set-up to analyze the chemical content and to simulate the migratory behavior of ICG-nanocolloid in tissue. Tracer accumulation and intraoperative fluorescence detection findings were derived from a retrospective analysis of 20 head-and-neck melanoma patients, 40 penile and 20 prostate cancer patients scheduled for sentinel node (SN) biopsy using ICG-(99m)Tc-nanocolloid. In these patients, following tracer injection, single photon emission computed tomography fused with computed tomography (SPECT/CT) was used to identify the SN(s). The percentage injected dose (% ID), the amount of ICG (in nmol), and the concentration of ICG in the SNs (in μM) was assessed for SNs detected on SPECT/CT and correlated with the intraoperative fluorescence imaging findings. RESULTS: SEC determined that in the hybrid tracer formulation, 41 % (standard deviation: 12 %) of ICG was present in nanocolloid-bound form. In the SNs detected using fluorescence guidance a median of 0.88 % ID was present, compared to a median of 0.25 % ID in the non-fluorescent SNs (p-value < 0.001). The % ID values could be correlated to the amount ICG in a SN (range: 0.003–10.8 nmol) and the concentration of ICG in a SN (range: 0.006–64.6 μM). DISCUSSION: The ability to provide intraoperative fluorescence guidance is dependent on the amount and concentration of the fluorescent dye accumulated in the lesion(s) of interest. Our findings indicate that intraoperative fluorescence detection with ICG is possible above a μM concentration. Springer Berlin Heidelberg 2016-03-28 2016 /pmc/articles/PMC4969335/ /pubmed/27020580 http://dx.doi.org/10.1007/s00259-016-3372-y Text en © The Author(s) 2016 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Original Article KleinJan, Gijs H. Bunschoten, Anton van den Berg, Nynke S. Olmos, Renato A. Valdès Klop, W. Martin C. Horenblas, Simon van der Poel, Henk G. Wester, Hans-Jürgen van Leeuwen, Fijs W. B. Fluorescence guided surgery and tracer-dose, fact or fiction? |
title | Fluorescence guided surgery and tracer-dose, fact or fiction? |
title_full | Fluorescence guided surgery and tracer-dose, fact or fiction? |
title_fullStr | Fluorescence guided surgery and tracer-dose, fact or fiction? |
title_full_unstemmed | Fluorescence guided surgery and tracer-dose, fact or fiction? |
title_short | Fluorescence guided surgery and tracer-dose, fact or fiction? |
title_sort | fluorescence guided surgery and tracer-dose, fact or fiction? |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4969335/ https://www.ncbi.nlm.nih.gov/pubmed/27020580 http://dx.doi.org/10.1007/s00259-016-3372-y |
work_keys_str_mv | AT kleinjangijsh fluorescenceguidedsurgeryandtracerdosefactorfiction AT bunschotenanton fluorescenceguidedsurgeryandtracerdosefactorfiction AT vandenbergnynkes fluorescenceguidedsurgeryandtracerdosefactorfiction AT olmosrenatoavaldes fluorescenceguidedsurgeryandtracerdosefactorfiction AT klopwmartinc fluorescenceguidedsurgeryandtracerdosefactorfiction AT horenblassimon fluorescenceguidedsurgeryandtracerdosefactorfiction AT vanderpoelhenkg fluorescenceguidedsurgeryandtracerdosefactorfiction AT westerhansjurgen fluorescenceguidedsurgeryandtracerdosefactorfiction AT vanleeuwenfijswb fluorescenceguidedsurgeryandtracerdosefactorfiction |